Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

"We are seeing more and more treatment trials that are focused on disease modification for both Alzheimer's and Lewy body diseases. Having validated clinical criteria to diagnose DLB before ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...

The National Institutes of Health reports that incidences of Alzheimer’s disease and other dementia increased by roughly 148 ...

The details of the presentation will be accessible in the Investor section of the CervoMed website following the presentation. CervoMed Inc. is a clinical-stage company focused on developing ...

Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). Historically, LBD has not been sufficiently prioritized, described or supported in research funding; Continuing Medical ...